DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products ...
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to ...
Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from ...
Hosted on MSN5mon
Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's likeDexcom launched its first over-the-counter continuous ... which is updated every 15 minutes. They'll also see a graph of their readings each day, which includes a shaded green area to indicate ...
Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...
The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...
Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors for people with diabetes—just weeks after a ...
Furthermore, you'd generally like to see... Investing.com -- Baird upgraded DexCom Inc (NASDAQ:DXCM). to "Outperform" from "Neutral," citing progress in U.S. sales and upcoming catalysts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback